Dallas TX – Sept. 24, 2026 – Investors are watching DarkHorse Technologies Inc. (NASDAQ: DRK), Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), Greenland Energy Company (NASDAQ: GLND) and Glucotrack, Inc. (NASDAQ: GCTK) as new developments span AI data centers, digital infrastructure, Greenland energy exploration and biotechnology financing.
DarkHorse Technologies Inc. (NASDAQ: DRK) is advancing its AI infrastructure and high-performance computing (HPC) data center strategy across the Tennessee Valley Authority region, adding strategic relationships with Empirix Partners, Covectis, Perpetual Grid and Barge Design Solutions to support project planning, equipment procurement, utility coordination, go-to-market strategy, and architectural and engineering design for its Tennessee and Kentucky assets. Initial work is underway to determine improvements, costs and schedules required to prepare sites for AI, HPC and GPU-intensive workloads. DRK has also established a higher recent trading range, reaching an intraday high of $3.27 on Sept. 18 after trading around the low-$2 range in late August, putting both operational progress and recent share-price momentum in focus.
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations has signed a 12-month technology-services agreement with Singapore-based AQUAE Holdings to design, deploy, host and support AQUAEChain, a platform for insured ALCI Credits. MindWave will earn contracted software-development and technology-service fees and is also entitled under the agreement to an allocation equal to 20% of total ALCI Credits issued and outstanding on AQUAEChain, calculated quarterly. The companies also intend to pursue a five-year continuing-services arrangement following the initial term, subject to definitive documentation.
Greenland Energy Company (NASDAQ: GLND) has amended its farm-out arrangement with 80 Mile plc (AIM: 80M) covering the Jameson Land Basin in East Greenland, extending the longstop dates for both planned exploration wells to Dec. 31, 2028. Greenland Energy will assume direct responsibility and cost for securing and maintaining required drilling permits and approvals and will pay 80 Mile £500,000 in connection with the amendments. The revised structure provides GLND additional time and greater direct control over advancing Jameson Land while also placing greater permitting responsibility and execution risk with the company.
Glucotrack, Inc. (NASDAQ: GCTK), which operates Lōkahi Therapeutics while continuing development of its investigational long-term implantable continuous blood-glucose monitoring technology, has priced a best-efforts public offering expected to generate approximately $3.1 million in gross proceeds. The financing includes 169,388 common shares at $2.04 per share and pre-funded warrants covering up to 1,350,220 shares at $2.039 per warrant, with Dawson James Securities acting as sole placement agent. The additional capital provides financial flexibility as Lōkahi advances therapeutic opportunities through its ai² platform and Futures Lab model.
Together, DRK, APUS, GLND and GCTK highlight four emerging-growth companies pursuing distinct opportunities across AI infrastructure, digital platforms, energy exploration and biotechnology, with new partnerships, agreements, project milestones and financing activity providing investors with multiple developments to follow.
About the Companies
DarkHorse Technologies Inc. (NASDAQ: DRK) develops energized power and data center infrastructure for artificial intelligence, high-performance computing and GPU-intensive workloads across Tennessee, Kentucky and the broader TVA region.
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) operates through businesses including MindWave Innovations, which develops technology infrastructure and digital platforms, including its MindChain technology.
Greenland Energy Company (NASDAQ: GLND) is an exploration-stage energy company focused on advancing hydrocarbon opportunities in Greenland, led by its interests in the Jameson Land Basin.
Glucotrack, Inc. (NASDAQ: GCTK) operates Lōkahi Therapeutics while its Glucotrack Technologies subsidiary continues development of an investigational long-term implantable continuous blood-glucose monitoring system.
About The Street Reports
The Street Reports (TSR) is a financial media awareness platform focused on emerging-growth, small-cap, micro-cap and nano-cap companies. The Street Reports publishes and distributes market-focused content across financial news, media and digital channels, providing companies with expanded visibility and exposure to a broad audience of readers and market participants.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media ContactCompany Name: The Street ReportsContact Person: EditorEmail: Send EmailCountry: United StatesWebsite: http://www.thestreetreports.com
